Model Medicines COVID-19 Drug Development Program Highlighted by Catalyst Health 2.0
Press Coverage

Patrick ONeill

Health Tech Responds to COVID-19

Patrick ONeill
Head of Partnerships and Investor Relations
The Health Tech Responds to COVID-19 website is a production of Catalyst @ Health 2.0 (“Catalyst”). We believe in digital health’s ability to facilitate the response to COVID-19 and are committed to providing current information and resources on the digital health ecosystem’s response. Catalyst’s global network of health information technology entrepreneurs, software developers, health care provider and payer organizations, pharmaceutical companies, philanthropic foundations, physicians, and government representatives are utilizing their resources to address the virus.
This article originally appeared on Catalyst @ Health 2.0 (“Catalyst”), prior to the rebrand of Repurpose.AI to Model Medicines, read the full article here.

